Table 2.
Delivery characteristics by treatment group.
| Characteristics | Activea (n=726) |
Controlb (n=718) |
P |
|---|---|---|---|
| Systolic blood pressure at delivery | 132.8 ± 10.3 | 133.1 ± 10.3 | 0.62 |
| Diastolic blood pressure at delivery | 79.0 ± 7.8 | 79.5 ± 8.3 | 0.19 |
| Mode of Delivery | |||
| Spontaneous vaginal | 343 (47.2) | 331 (46.1) | 0.88 |
| Operative vaginal | 11 (1.5) | 10 (1.4) | |
| Cesarean delivery | 372 (51.2) | 377 (52.5) | |
| Discharged on Medication | 638 (87.9) | 367 (51.1) | <0.0001 |
| Labetalol | 350 (48.2) | 185 (25.8) | <0.0001 |
| Nifedipine | 274 (37.7) | 183 (25.5) | <0.0001 |
Data presented as n (percentage) or mean ± standard deviation.
a
Active treatment group was randomized to receive antihypertensive medications with goal blood pressure of < 140/90 mm Hg.
b
Control group was randomized to defer antihypertensive treatment until blood pressure ≥ 160/105 mm Hg.